RTSN · Company research
Retension Pharmaceuticals, Inc. Common Stock (RTSN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
12records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| RETENSION PHARM (RTSN) - Zacks Investment Research | RETENSION PHARM (RTSN) Zacks Investment Research | View source ↗ | Zacks Investment Research | Oct 14, 2026 | neutral | 0 | 0.6 |
| Director Pavan Cheruvu receives 5,636 stock options at Retension Pharmaceuticals (RTSN). - Stock Titan | Director Pavan Cheruvu receives 5,636 stock options at Retension Pharmaceuticals (RTSN). Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| With 402,577 common shares, Retension Pharmaceuticals (RTSN) CEO also holds options priced from $1.43. - Stock Titan | With 402,577 common shares, Retension Pharmaceuticals (RTSN) CEO also holds options priced from $1.43. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| CEO buys 20,800 shares and receives 255,174 stock options at Retension Pharmaceuticals (RTSN). - Stock Titan | CEO buys 20,800 shares and receives 255,174 stock options at Retension Pharmaceuticals (RTSN). Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| A director buys at $12 a share and converts preferred stock at Retension Pharmaceuticals (RTSN). - Stock Titan | A director buys at $12 a share and converts preferred stock at Retension Pharmaceuticals (RTSN). Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| Director Berger receives 5,636 options at Retension (RTSN) with a $12 exercise price. - Stock Titan | Director Berger receives 5,636 options at Retension (RTSN) with a $12 exercise price. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| Biotech Stocks At 52-Week Highs - RTSN Rises With IPO, BIIB, CON, HNGE, HSTM - RTTNews | Biotech Stocks At 52-Week Highs - RTSN Rises With IPO, BIIB, CON, HNGE, HSTM RTTNews | View source ↗ | RTTNews | Oct 13, 2026 | neutral | 0 | 0.6 |
| Average basic shares outstanding of Retension Pharmaceuticals, Inc. – NASDAQ:RTSN - TradingView | Average basic shares outstanding of Retension Pharmaceuticals, Inc. – NASDAQ:RTSN TradingView | View source ↗ | TradingView | Oct 13, 2026 | neutral | 0 | 0.6 |
| Retension Pharmaceuticals, Inc. (RTSN) stock price, news, quote and history - Yahoo Finance UK | Retension Pharmaceuticals, Inc. (RTSN) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 11, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Oct 11, 2026 | neutral | 0 | 0.6 |
| Retension Pharmaceuticals, Inc. (RTSN) stock price, news, quote and history - Yahoo Finance UK | Retension Pharmaceuticals, Inc. (RTSN) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 10, 2026 | neutral | 0 | 0.6 |
| Retension Pharmaceuticals, Inc. Common Stock (RTSN) valuation measures and financial statistics - Yahoo Finance UK | Retension Pharmaceuticals, Inc. Common Stock (RTSN) valuation measures and financial statistics Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 10, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.